Pharmacological, Clinical and Statistical Assessment of a New Tool Available for Pharmacodependence Report Evaluation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Nantes University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Nantes University Hospital
ClinicalTrials.gov Identifier:
NCT01052675
First received: January 19, 2010
Last updated: January 31, 2012
Last verified: January 2010
  Purpose

In France, the Afssaps is the body in charge of the evaluation of pharmacodependance. In order to fulfil its mission, the Afssaps has created a network of 11 Centres for Evaluation and Information on Pharmacodependance (CEIP), coordinated by the Drugs and Psychotropics Unit. Pharmacodependence notifications issued by professionals are collected by each Centre which evaluates them. Nantes' CEIP created an original tool to harmonize case reporting and make it possible to homogeneously evaluate the seriousness of pharmacodependence cases as each CEIP had his own way of analysing his cases. The aim of this study is to assess this tool.


Condition
Drug Abuse
Drug Dependence

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Pharmacological, Clinical and Statistical Assessment of a New Tool Available for Pharmacodependence Report Evaluation

Further study details as provided by Nantes University Hospital:

Primary Outcome Measures:
  • Psychometrics properties Evaluation of the new questionnaire centered on addiction to medicine . [ Time Frame: At the beginning of the study ] [ Designated as safety issue: No ]

Estimated Enrollment: 5000
Study Start Date: January 2008
Groups/Cohorts
Pharmacodependance cases
Case report from one of the French CEIP for drug and substance problematic use, abuse or dependence except alcohol and tobacco.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Pharmacodependent patients

Criteria

Inclusion Criteria:

  • case report from one of the French CEIP for drug and substance problematic use, abuse or dependence except alcohol and tobacco.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01052675

Contacts
Contact: Pascale Jolliet Pascale pascale.jolliet@chu-nantes.fr

Locations
France
Hôpital Pellegrin Recruiting
Bordeaux, France, 33076
CHRU de Caen Recruiting
Caen, France, 14033
CHU de Grenoble Recruiting
Grenoble, France, 38043
Centre Antipoison - Centre de Pharmacovigilance Recruiting
Lyon, France, 69424
Hôpital Salvator Recruiting
Marseille, France, 13274
Hôpital Lapeyronie Recruiting
Montpellier, France, 34295
CHU de Nancy Recruiting
Nancy, France, 54035
CHU de Nantes Recruiting
Nantes, France, 44093
Hôpital Fernand Widal Recruiting
Paris, France, 75475
Faculté de médecine Recruiting
Toulouse, France, 31073
Sponsors and Collaborators
Nantes University Hospital
Investigators
Study Director: Jolliet Pascale, MD Nantes's University Hospital
  More Information

No publications provided

Responsible Party: Nantes University Hospital
ClinicalTrials.gov Identifier: NCT01052675     History of Changes
Other Study ID Numbers: BRD07/10-C
Study First Received: January 19, 2010
Last Updated: January 31, 2012
Health Authority: France: Ministry of Health

Keywords provided by Nantes University Hospital:
Drug and substance problematic use, abuse or dependence

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on September 14, 2014